Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To investigate whether in patients with chronic HBeAg-negative hepatitis B PEG-IFN-ribavirin combination therapy for 1 year leads to enhanced response (HBV DNA <104 copies/ml and normal ALT 24 weeks after treatment discontinuation) in comparison with PEG-IFN monotherapy.
Critère d'inclusion
- chronic HBV infection